FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
100
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

FIT Biotech Oy

Company release October 25, 2017 at 10:00 AM EET

Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the FIT Biotech Oy ("Company") and Bracknor Investment ("Bracknor") the Company's board of directors have  resolved on October 24, 2017 to approve Bracknor's request relating to the funding programme to convert EUR 70,000 worth of Convertible Capital Notes into the Company's K shares.

Due to the conversion of the Convertible Capital Notes, the Company issues 2,573,529 new K shares in the Company to Bracknor with the conversion price of EUR 0.027200 per share.

As a result of the issue of the new K shares in the Company, the total number of shares in the Company will increase to 85,122,578 shares, and the share capital of the Company will be increased by EUR 69,999.99. After the issue of the new K shares in the Company, the Company's shares will be divided in share series as follows: 85,052,114 K shares, 5,229 A shares and 65,235 D shares.

The increase of the share capital and new K shares in the Company will be registered in the Trade Register on or about October 26, 2017 and the new K shares will be admitted to trading on First North Finland on or about October 27, 2017.

FIT BIOTECH OY

Board of Directors

For further information: Chairman of the Board of Directors Rabbe Slätis E-mail: rabbe.slatis@fitbiotech.com

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: NASDAQ OMX Helsinki Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 8

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading
Banco Santander's Troubles: Legal Heat on SAN

Updated Category News Views 0

Brazilian Turbulence Shakes Banco Santander Imagine getting hit twice in a single week, once by a surprise election result and again by numbers that don't add up. That's the gut-wrenching scenario Banco Santander's (NYSE: SAN) investors are facing. After Brazil's unexpected election outcome, investor jitters translated into a 3.7% drop on October 26, 2026. Not two days...

Continue Reading
Pelvic Health Initiative Aids Women in Need

Updated Category News Views 5

Stepping Up For Better Health You don't see this kind of news getting plastered across the financial pages much—the human side of health. EliHealth Initiative's making strides in a realm many don’t even want to openly discuss: bladder leaks in women. Sounds unglamorous, maybe, but for millions, it's a daily ordeal. Slapping on pads and plotting bathroom routes? That's...

Continue Reading
Summit Hotel Welcomes New CFO, Promotes Veteran COO

Updated Category News Views 0

Summit Hotel Properties Shakes Up Leadership Ah, the hotel industry. Sometimes as glitz and glam as Beverly Hills, sometimes as harried as a concierge juggling suitcases. Now, Summit Hotel Properties is playing its hand, reshuffling the deck with some keen leadership moves. Swapping out the four of spades for some aces, if you ask me. On November 1st, they’re bringing...

Continue Reading
Sage Longboat Key Condos Battle Florida's Marine Climate

Updated Category News Views 29

Building Resilience on Florida's Shores If you've ever had your eyes on some beachfront real estate down in Florida, you'd know it's not all sandy beaches and sunsets. It's a constant battle against the elements, my friends. The Sage Longboat Key condominiums in Sarasota have taken this challenge head-on with some serious innovation. The Condominium Dream Sitting pretty...

Continue Reading
JOIA Rose Hall Revives Jamaican Luxury Experience

Updated Category News Views 8

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Continue Reading
Tata's $450M Bet on India's AI Infrastructure

Updated Category News Views 28

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 17

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading
Max Stock Gears Up for Q3 Earnings Report Nov. 17

Updated Category News Views 83

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Continue Reading
Keith Strachan Elevates The Master Group's Strategy

Updated Category News Views 0

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

Continue Reading

Top 5 Most Recently Viewed Articles

Streamlined Website Security Management for SMBs Introduced

Updated Category News Views 59

Introducing SiteLock 2.0: A Game Changer for SMBs Sectigo, a leading expert in digital certificates and Certificate Lifecycle Management (CLM), has made waves with the launch of SiteLock 2.0. This innovative upgrade redefines website security, particularly for small to medium-sized businesses (SMBs). Understanding the challenges faced by SMBs in managing website security,...

Continue Reading
Michelin's Recent Share Trading Activity Analysis

Updated Category News Views 134

Understanding Michelin's Share Trading Activities Michelin is well known for its commitment to maintaining shareholder value through strategic financial maneuvers. Recently, the company has disclosed significant trading activities in its own shares, which highlight its ongoing efforts to enhance liquidity and overall investor confidence. Details of the Share Buyback...

Continue Reading
MariMed Plans Earnings Call to Discuss Third Quarter Results

Updated Category News Views 135

MariMed Earnings Announcement and Call Details MariMed Inc. (CSE: MRMD) (OTCQX: MRMD), a prominent name in the cannabis industry, has confirmed that its financial results for the third quarter of 2025 will be released on November 5, 2025, after the market closes. This announcement is vital for investors, stakeholders, and anyone interested in the company's financial...

Continue Reading
Toll Brothers Stock: A Look at 15 Years of Growth

Updated Category News Views 142

The Impressive Journey of Toll Brothers Stock Toll Brothers (NYSE: TOL) has demonstrated remarkable resilience and growth over the past 15 years. With an average annual return of 14.07%, it has outperformed the market by 1.87%. As of now, the company's market capitalization stands at an impressive $12.22 billion. Investment Potential: What If You Bought $1,000? Imagine...

Continue Reading
Mantle Ridge's Call to Action: Vote Now for Change at Air Products

Updated Category News Views 204

Empowering Change: The Mantle Ridge Initiative Change is inevitable, especially in the corporate sector, and Mantle Ridge is on a mission to promote significant reform at Air Products and Chemicals, Inc. With a firm belief that progress can only be achieved through effective governance, Mantle Ridge has identified four shareholder nominees poised to facilitate this...

Continue Reading